The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: Design of a phase III trial in the united states and canada

Journal of Stroke and Cerebrovascular Diseases

Volumn 7, Issue 6, 1998, Pages 435-441

  Lyden, Patrick D ^a,b,c,d   Ashwood, Timothy ^a,b,c,d   Claesson, Lennart ^a,b,c,d   Odergren, Tomas ^a,b,c,d   Friday, Gary H ^a,b,c,d   Martin Munley, Sarah ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c Astra Arcus   (United States)

^d Astra USA   (United States)

Author keywords

GABA; Hematoma; Stroke; Therapy

Indexed keywords

EID: 0000450747     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3057(98)80128-6     Document Type: Article

References (30)

1. Cross A.J., Jones J.A., Baldwin H.A., et al. Neuroprotective activity of chlomethiazole following transient forebrain ischaemia in the gerbil. Br J Pharmacol 104 (1991) 406-411
2. Cross A.J., Jones T.A., Snares M., et al. The protective action of chlomethiazole against ischemia-induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity. Br J Pharmacol 114 (1995) 1625-1630
3. Sydserff S.G., Cross A.J., and Green A.R. The neuroprotective effect of chlomethiazole on ischemic neuronal damage following permanent middle cerebral artery ischemia in the rat. Neurodegeneration 4 (1995) 323-328
4. Sydserff S.G., Cross A.J., West K.J., et al. The effect of chlomethiazole on ischemic neuronal damage in a model of transient focal ischemia. Br J Pharmacol 114 (1995) 1631-1635
5. Snape M.F., Baldwin H.A., Cross A.J., et al. The effects of chlomethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat. Neuroscience 53 (1993) 837-844
6. Lyden P.D. GABA and neuroprotection. In: Green A.R., and Cross A.J. (Eds). Neuroprotective agents and cerebral ischemia (1997), Academic, London 233-258
7. (abstr). Marshall J., Cross A.J., Murray T., and Ridley R. Clomethiazole treatment ameliorates the motor disabilty produced by focal cerebral ischemia in a non-human primate species. Stroke 29 (1998) 330
8. Green A.R., and Cross A.J. The neuroprotective actions of clomethiazole. Prog Neurobiol 44 (1994) 463-484
9. Cross A.J., Stirling J.M., Robinson T.N., et al. The modulation by clomethiazole of the GABA-A receptor complex in rat brain. Br J Pharmacol 98 (1989) 284-290
10. (abstr). Lyden P.D., and Nunez S.I. Combination of GABA agonist and glutamate antagonist protects rat brain up to 1 hour after focal ischemia. Stroke 24 (1993) 178
11. Shuaib A., Mazagri R., and Ijaz S. GABA agonist "muscimol" is neuroprotective in repetitive transient forebrain ischemia in gerbils. Exp Neurol 123 (1993) 284-288
12. madden K. Effect of gamma-aminobutyric acid modulation on neuronal ischemia in rabbits. Stroke 25 (1994) 2271-2275
13. Shuaib A., Ijaz M.S., Waqar T., et al. Insulin elevates hippocampal GABA levels during ischemia. This is independent of its hypoglycemic effect. Neuroscience 67 (1995) 809-814.
14. Shuaib A., Ijaz S., and Kanthan R. Clomethiazole protects the brain in transient forebrain ischemia when used up to 4 hours after the insult. Neurosci Lett 197 (1995) 109-112
15. Wester P., Strand T., Wahlgren N.G., et al. An open study of clomethiazole in patients with acute cerebral infarction. Cerebrovasc Dis 8 (1998) 188-190
16. Wahlgren N.G. The clomethiazole Acute Stroke Study (CLASS). Efficacy results in a subgroup of 545 patients with total anterior circulation syndrome. Stroke 29 (1998) 287
17. Bamford J., Sandercock P., Dennis M., et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337 (1991) 1521-1526
18. Broderick J.P., Brott T.G., Duldner J.E., et al. Volume of intracerebral hemorrhage: A powerful and easy-to-use predictor of 30-day mortality. Stroke 24 (1993) 987-993
19. Wade D.T., and Collin C. The Barthel ADL Index: A standard measure of physical disability?. Int Disabil Stud 10 (1988) 64-67
20. Granger C.V., Dewis L.S., Peters N.C., et al. Stroke rehabilitation: Analysis of repeated Barthel Index measures. Arch Phys Med Rehabil 60 (1979) 14-17
21. Rankin J. Cerebral vascular accidents in patients over the age of 60: Prognosis. Scott Med J 2 (1957) 200-215
22. Lyden P.D., and Lau G.T. A critical appraisal of stroke evaluation and rating scales. Stroke 22 (1991) 1345-1352
23. Lyden P., Brott T., Tilley B., et al. Improved reliability of the NIH stroke scale using video training. Stroke 25 (1994) 2220-2226
24. Lindenstrom E., Boysen G., Christiansen L.W., et al. Reliability of Scandinavian neurological stroke scale. Cerebrovasc Dis 1 (1991) 103-107
25. Boysen G. Stroke scores and scales. Cerebrovasc Dis 2 (1992) 239-247
26. lindgren A., Norrving B., Rudling O., et al. Comparison of clinical and neuroradiological findings in first-ever stroke. A population-based study. Stroke 25 (1994) 1371-1377
27. Grotta J. The current status of neuronal protective therapy: Why have all neuronal protective drugs worked in animals but none so far in stroke patients?. Cerebrovasc Dis 4 (1994) 115-120
28. Heinemann A.W., Roth E.J., Cichowski K., et al. Multivariate analysis of improvement and outcome following stroke rehabilitation. Arch Neurol 44 (1987) 1167-1172
29. Wade D.T., and Hewer R.L. Functional abilities after stroke: Measurement, natural history and prognosis. J Neurol Neurosurg Psychiatry 50 (1987) 177-182
30. Wade D.T., Skilbeck C.E., and Hewer R.L. Predicting Barthel ADL score at 6 months after an acute stroke. Arch Phys Med Rehabil 64 (1983) 24-28